In this episode, Josh Levitsky, MD, MS, professor of Medicine in the Divisions of Gastroenterology and Hepatology, Medical Education and Organ Transplantation at Northwestern Medicine, discusses the grant he received to conduct a clinical trial on the utility of biomarkers of rejection and kidney injury in tailoring liver transplant immunosuppression, and what findings could mean for the future of liver transplantation.
